Our Beacon Checkpoint research team and the producers of the 2023 Adenosine-Targeted Cancer Immunotherapies Summit have carefully crafted this free infographic to provide you with a deep dive into the adenosine-pathway clinical trial landscape, using data from the Beacon Checkpoint database.
The data in this infographic reviews:
- The number of adenosine-pathway targeted therapies entering the clinic since 2011.
- Status and modalities of adenosine-pathway targeted therapies.
- Clinical trials by phase over the years.
- Top disease indications.
To learn more about the adenosine landscape and how Beacon Checkpoint can enhance your data needs and provide fast insights, please book a research session below or contact us directly at firstname.lastname@example.org.